Goal Attainment and Physical Activity in People With Hemophilia A
← catalyst calendarSponsored by Sanofi (industry) · SNY — their whole pipeline →.
Phase
—
Status
Terminated
Study type
Observational
Enrollment
3actual
Sites
1
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Why the sponsor stopped it
Early discontinuation based on sponsor decision not driven by any safety concerns.
As filed on the registry record, in the sponsor's own words.
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2024-11-26 | actual | When the study began enrolling |
| Primary completion | 2025-09-18 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2025-09-18 | actual | The whole study's end, after follow-up |
| First posted | 2024-07-31 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-01-20 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Hemophilia A
Intervention
- Drug: efanesoctocog alfa — also filed as Altuviiio
Primary outcomes
what the primary-completion date above is the date OFProportion of total goals achieved
measured Month 3
Proportion of total goals achieved
measured Month 6
Proportion of total goals achieved
measured Month 9
Proportion of total goals achieved
measured Month 12
Proportion of patients who reached a +2 or +1 on at least one goal
measured Month 3
Proportion of patients who reached a +2 or +1 on at least one goal
measured Month 6
Proportion of patients who reached a +2 or +1 on at least one goal
measured Month 9
Proportion of patients who reached a +2 or +1 on at least one goal
measured Month 12
Overall GAS score
measured Month 3
Overall GAS score
measured Month 6
Overall GAS score
measured Month 9
Overall GAS score
measured Month 12
Frequency of selection of category of physical activity
measured Baseline
Monthly average of daily step count
measured From Baseline to Month 12
Monthly average of daily activity count
measured From Baseline to Month 12
Monthly average of daily Metabolic equivalent of tasks (MET)
measured From Baseline to Month 12
Monthly average of daily Moderate and Vigorous Physical Activity (MVPA)
measured From Baseline to Month 12
Monthly average of daily intensity gradient
measured From Baseline to Month 12
Monthly average of weekly intensity gradient
measured From Baseline to Month 12
Permalink · SNY's whole pipeline · Catalyst calendar · Every registered study · What changed